These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 6193751)

  • 41. [Programmed stimulation in patients with malignant ventricular arrhythmia. II: Individual optimization of anti-arrhythmia therapy].
    Senges J; Lengfelder W; Jauernig R; Brachmann J; Rizos I; Kübler W
    Herz; 1984 Apr; 9(2):77-82. PubMed ID: 6714917
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Effect of using a mexitil preparation in cardiac rhythm disorders].
    Dimitrov D; Dzhurdzhev A; Batalov Z
    Vutr Boles; 1981; 20(1):71-5. PubMed ID: 7245728
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antiarrhythmic effect of lorcainide during chronic treatment.
    Meinertz T; Kasper W; Kersting F; Bechtold H; Just H; Jähnchen E
    Arzneimittelforschung; 1980; 30(9):1593-5. PubMed ID: 7193031
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Flecainide: a new antiarrhythmic drug.
    Med Lett Drugs Ther; 1986 Feb; 28(707):19-20. PubMed ID: 3951388
    [No Abstract]   [Full Text] [Related]  

  • 45. Clinical experience with lorcainide (R 15 889), a new anti-arrhythmic drug.
    Kesteloot H; Stroobandt R
    Arch Int Pharmacodyn Ther; 1977 Dec; 230(2):225-34. PubMed ID: 603318
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relationship between plasma concentrations and suppression of ventricular extrasystoles by flecainide acetate (R-818), a new antiarrhythmic, in patients.
    Conard GJ; Cronheim GE; Klempt HW
    Arzneimittelforschung; 1982; 32(2):155-9. PubMed ID: 7199921
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Tiracizine in the treatment of ventricular arrhythmia (preliminary study)].
    Stejfa M; Zeman K; Groch L; Bytesník J; Krausová R
    Vnitr Lek; 1993 Jun; 39(6):549-53. PubMed ID: 8212608
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Antiarrhythmic therapy with flecainide in acute experimental myocardial infarction (author's transl)].
    Gülker H; Bender F; Brisse B; Thale J; Heuer H; Kristek J; Schindelhauer F; Teerling K
    Z Kardiol; 1981 Feb; 70(2):124-30. PubMed ID: 7222906
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Dangerous arrhythmias].
    Gertsch M; Fuhrer J
    Schweiz Med Wochenschr; 1993 May; 123(17):833-43. PubMed ID: 8497770
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Efficacy of oral bepridil in ventricular arrhythmias in stable coronary insufficiency].
    Rio A; Pasco A; Dupont T; Deroubaix G; Moulinie E; Rossignol B; Pellet J; Brechenmacher C
    Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():75-8. PubMed ID: 3938263
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Amiodarone-flecainide combination in the treatment of severe ventricular arrhythmia].
    Fontaine G; Frank R; Tonet JL
    Arch Mal Coeur Vaiss; 1984 Nov; 77(12):1421-2. PubMed ID: 6439167
    [No Abstract]   [Full Text] [Related]  

  • 52. Flecainide versus quinidine: results of a multicenter trial.
    Hodges M; Salerno DM; Granrud G
    Am J Cardiol; 1984 Feb; 53(5):66B-71B. PubMed ID: 6364770
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Treatment of tachycardiac arrhythmias and arterial hypertension with verapamil].
    Bender F
    Arzneimittelforschung; 1970 Sep; 20():Suppl 9a:1310+. PubMed ID: 4098332
    [No Abstract]   [Full Text] [Related]  

  • 54. [Clinical study of the antiarrhythmic action of Mexityl in ventricular disorders of the cardiac rhythm].
    Mazur NA; Liakishev AA; Podrid FD; Piotrovskiĭ VK
    Kardiologiia; 1979 Oct; 19(10):17-21. PubMed ID: 91699
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sinusoidal ventricular tachycardia associated with flecainide acetate.
    Sellers TD; DiMarco JP
    Chest; 1984 May; 85(5):647-9. PubMed ID: 6201323
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Use of flecainide acetate in the treatment of premature ventricular contractions.
    Abitbol H; Califano JE; Abate C; Beilis P; Castellanos H
    Am Heart J; 1983 Feb; 105(2):227-30. PubMed ID: 6823803
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Double-blind randomized placebo-controlled study of the effects of slow release and immediate release forms of propafenone in patients ventricular extrasystole symptoms].
    Mastropasqua F; Totaro P; Massari F; Pitzalis MV; Rizzon P
    Cardiologia; 1998 Jun; 43(6):617-23. PubMed ID: 9675961
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of the efficacy of flecainide acetate in the treatment of ventricular premature contractions.
    Muhiddin KA; Turner P; Hellestrand K; Camm AJ
    Postgrad Med J; 1985 Jun; 61(716):489-96. PubMed ID: 2409543
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use of a combination of class III and class Ic antiarrhythmic agents in patients with electrical storm.
    Fuchs T; Groysman R; Meilichov I
    Pharmacotherapy; 2008 Jan; 28(1):14-9. PubMed ID: 18154469
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Flecainide: steady state electrophysiologic effects in patients with remote myocardial infarction and inducible sustained ventricular arrhythmia.
    Webb CR; Morganroth J; Senior S; Spielman SR; Greenspan AM; Horowitz LN
    J Am Coll Cardiol; 1986 Jul; 8(1):214-20. PubMed ID: 3711519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.